Suppr超能文献

循环的G1期CD34+/CD38+细胞增强了静止的G0期CD34+/CD38-/低表达重症联合免疫缺陷再填充细胞的运动能力和植入能力。

Cycling G1 CD34+/CD38+ cells potentiate the motility and engraftment of quiescent G0 CD34+/CD38-/low severe combined immunodeficiency repopulating cells.

作者信息

Byk Tamara, Kahn Joy, Kollet Orit, Petit Isabelle, Samira Sarit, Shivtiel Shoham, Ben-Hur Herzl, Peled Amnon, Piacibello Wanda, Lapidot Tsvee

机构信息

The Weizmann Institute of Science, Department of Immunology, P.O. Box 26, Rehovot 76100, Israel.

出版信息

Stem Cells. 2005 Apr;23(4):561-74. doi: 10.1634/stemcells.2004-0060.

Abstract

The mechanism of human stem cell expansion ex vivo is not fully understood. Furthermore, little is known about the mechanisms of human stem cell homing/repopulation and the role that differentiating progenitor cells may play in these processes. We report that 2- to 3-day in vitro cytokine stimulation of human cord blood CD34(+)-enriched cells induces the production of short-term repopulating, cycling G1 CD34(+)/CD38(+) cells with increased matrix metalloproteinase (MMP)-9 secretion as well as increased migration capacity to the chemokine stromal cell-derived factor-1 (SDF-1) and homing to the bone marrow of irradiated nonobese diabetic severe/combined immunodeficiency (NOD/SCID) mice. These cycling G1 cells enhance SDF-1-mediated in vitro migration and in vivo homing of quiescent G0 CD34(+) cells, which is partially abrogated after inhibition of MMP-2/-9 activity. Moreover, the engraftment potential of quiescent G0 SCID repopulating cells (SRCs) is also increased by the cycling G1 CD34(+)/CD38(+) cells. This effect is significantly abrogated after incubation of cycling G1 cells with a neutralizing anti-CXCR4 antibody. Our data suggest synergistic interactions between accessory cycling G1 CD34(+)/CD38(+) committed progenitor cells and quiescent, primitive G0 CD34(+)/CD38(-/low) SRC/stem cells, the former increasing the motility and engraftment potential of the latter, partly via secretion of MMP-9.

摘要

人类干细胞体外扩增的机制尚未完全明了。此外,对于人类干细胞归巢/再增殖的机制以及分化祖细胞在这些过程中可能发挥的作用,人们知之甚少。我们报告称,对富集人脐带血CD34(+)细胞进行2至3天的体外细胞因子刺激,可诱导产生短期再增殖的、处于细胞周期G1期的CD34(+)/CD38(+)细胞,这些细胞的基质金属蛋白酶(MMP)-9分泌增加,对趋化因子基质细胞衍生因子-1(SDF-1)的迁移能力增强,并能归巢至受照射的非肥胖糖尿病严重联合免疫缺陷(NOD/SCID)小鼠的骨髓。这些处于细胞周期G1期的细胞可增强SDF-1介导的静止G0期CD34(+)细胞的体外迁移和体内归巢能力,在抑制MMP-2/-9活性后,这种能力会部分丧失。此外,处于细胞周期G1期的CD34(+)/CD38(+)细胞还可增加静止G0期严重联合免疫缺陷再增殖细胞(SRC)的植入潜力。在用中和性抗CXCR4抗体孵育处于细胞周期G1期的细胞后,这种效应会显著减弱。我们的数据表明,处于细胞周期G1期的辅助性CD34(+)/CD38(+)定向祖细胞与静止的、原始的G0期CD34(+)/CD38(-/低)SRC/干细胞之间存在协同相互作用,前者部分通过分泌MMP-9来增加后者的迁移能力和植入潜力。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验